Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Blandine Rammaert is active.

Publication


Featured researches published by Blandine Rammaert.


Diabetes & Metabolism | 2012

Diabetes and mucormycosis: A complex interplay

Blandine Rammaert; Fanny Lanternier; S. Poirée; Romain Kania; Olivier Lortholary

Mucormycosis is a life-threatening invasive fungal infection that arises particularly in diabetic patients with or without other underlying conditions such as haematological malignancies or the need for solid-organ transplantation. Rhino-orbito-cerebral involvement is the primary site of mucormycosis, but the paucity of signs may be a cause of delayed diagnosis. Thus, any case of documented non-bacteriological sinusitis in diabetic patients, even without ketoacidosis, should prompt suspicion of a mucormycosis diagnosis. To optimalize information for clinicians in charge of diabetic patients, this extensive review of the literature was carried out to provide an overview of mucormycosis specificities, epidemiology and pathophysiology in the setting of diabetes.


BMC Infectious Diseases | 2011

Mycobacterium genavense as a cause of subacute pneumonia in patients with severe cellular immunodeficiency

Blandine Rammaert; Louis-Jean Couderc; Elisabeth Rivaud; Patrick Honderlick; David Zucman; Marie-France Mamzer; Pierre Cahen; Emmanuel Bille; Marc Lecuit; Olivier Lortholary; Emilie Catherinot

BackgroundMycobacterium genavense is a rare nontuberculous mycobacteria (NTM). Human infections are mostly disseminated in the setting of the AIDS epidemic or the use of aggressive immunosuppressive treatments. M. genavense culture is fastidious, requiring supplemented media. Pulmonary involvement rarely occurs as a primary localization.Cases presentationWe report here two patients with pneumonia as the predominant manifestation of M. genavense infection: one kidney transplanted patient and one HIV-infected patient. Both patients were initially treated with anti-tuberculous drugs before the identification of M. genavense on sputum or broncho-alveolar lavage fluid culture. A four-drug regimen including clarithromycin and rifabutin was started. Gamma interferon has been helpful in addition to antimycobacterial treatment for one patient.ConclusionClinicians should be aware that M. genavense could be the etiologic agent of sub-acute pneumonia mimicking tuberculosis in patients with cellular immunodeficiency status.


Current Infectious Disease Reports | 2012

Emerging Invasive Fungal Diseases in Transplantation

Perrine Parize; Blandine Rammaert; Olivier Lortholary

Invasive fungal infections continue to be a major cause of morbidity and mortality in severely immunocompromised transplant patients. Although Candida spp. and Aspergillus spp. represent the majority of identified pathogens, other fungi have become increasingly prevalent among this patient population. Diagnosis and treatment of invasive fungal infections remain a challenge in transplant medicine despite recent major advances. In this review, we will emphasize emerging topics in invasive fungal infections in transplantations that occurred in 2011–2012. The current literature was reviewed to synthesize new trends in epidemiology, recent outbreaks, clinical findings, and advances in diagnostic and therapeutic resources.


PLOS ONE | 2014

Etiologies and Resistance Profiles of Bacterial Community-Acquired Pneumonia in Cambodian and Neighboring Countries’ Health Care Settings: A Systematic Review (1995 to 2012)

Sophie Goyet; Erika Vlieghe; Varun Kumar; Steven W. Newell; Catrin E. Moore; Rachel Bousfield; Heng C. Leang; Sokheng Chuop; Phe Thong; Blandine Rammaert; Sopheak Hem; Johan van Griensven; Agus Rachmat; Thomas Fassier; Kruy Lim; Arnaud Tarantola

Objectives Community-acquired pneumonia (CAP) is one of the most important causes of morbidity and mortality worldwide. Etiological data for Cambodia is scarce. We aimed to describe the main etiological agents causing CAP, and their resistance patterns in Cambodia and the greater Mekong region. Methods A review of bacterial etiologies of CAP and antimicrobial resistance in Cambodia and neighboring countries was conducted via: (1) a systematic review of published literature in all NCBI databases using Pubmed, Google scholar, EMBASE, the World Health Organization and the Cambodian Ministry of Health libraries; (2) a review of unpublished data from Cambodia provided by national and international stakeholders working at different tiers of the healthcare system. Results Twenty three articles and five data sources reported etiologies for 5919 CAP patients diagnosed between May 1995 and December 2012, including 1421 (24.0%), 3571 (60.3%) and 927 (15.7%) from Cambodia, Thailand and Vietnam, respectively. Streptococcus pneumoniae and Haemophilus influenzae were the most common pathogens ranking among the five most prevalent in 12 and 10 studies, respectively. Gram-negative bacteria such as Burkholderia pseudomallei and Klebsiella pneumoniae were also frequently diagnosed, particularly in bacteremic CAP in Thai adults and Cambodian children. In Thailand and Vietnam, Mycoplasma pneumoniae and Chlamydia pneumoniae were frequently identified in settings using indirect laboratory testing. Conclusions Based on this analysis, CAP data in Cambodia seems to present etiological and resistance profiles comparable to those of neighboring countries. Findings have been shared with the national authorities upon the revision of the national therapeutic guidelines and were disseminated using a specially created website.


Medical mycology case reports | 2014

Mucor irregularis-associated cutaneous mucormycosis: Case report and review

Blandine Rammaert; Cécile Angebault; Anne Scemla; Sylvie Fraitag; Nathalie Lerolle; Marc Lecuit; Marie-Elisabeth Bougnoux; O. Lortholary

Solid organ transplant recipients are at risk for invasive fungal diseases, and are also exposed to healthcare-associated mucormycosis. Mainly causing localized cutaneous mucormycosis, Mucor irregularis infection is reported for the first time in a kidney-transplant recipient. A healthcare-associated origin was highly suspected in this case. We performed a literature review and highlight the characteristics of this very rare fungus.


International Journal of Infectious Diseases | 2013

Melioidosis in a European traveler without comorbidities: a case report and literature review

Benjamin Subran; Felix Ackermann; Luc Watin-Augouard; Blandine Rammaert; Claire Rivoisy; Didier Vilain; Anne-Marie Canzi; Jean-Emmanuel Kahn

Melioidosis is an endemic disease in Southeast Asia and northern Australia. It habitually affects immune-depressed hosts and may have a wide range of clinical manifestations. The use of positron emission tomography-computed tomography (PET-CT) has not been described previously for this disease. We report the case of a European traveler without comorbidities who developed melioidosis with pulmonary and bone marrow involvement 1 year after exposure. Antibiotic treatment was managed by taking into account the evolution on PET-CT. We review the literature and suggest the use of PET-CT for the initial evaluation of melioidosis, especially to look for a bone location, and to manage the length of antibiotic therapy.


Transplant Infectious Disease | 2016

Mycobacterium avium complex disseminated infection in a kidney transplant recipient.

J. Fadlallah; Blandine Rammaert; Sara Laurent; Fanny Lanternier; Stanislas Pol; N. Franck; M.F. Mamzer; Nicolas Dupin; O. Lortholary

Mycobacterium avium‐intracellulare complex (MAC) infections are well known in immunocompromised patients, notably in human immunodeficiency virus infection, but remain scarcely described in kidney transplantation. Moreover, cutaneous involvement in this infection is very unusual. We describe here a disseminated infection caused by MAC in a kidney transplant recipient revealed by cutaneous lesions. This case highlights the need for an exhaustive, iterative microbiologic workup in the context of an atypical disease presentation in a renal transplant patient, regardless of the degree of immunosuppression.


Antimicrobial Agents and Chemotherapy | 2015

Chronic Invasive Aspergillus Sinusitis and Otitis with Meningeal Extension Successfully Treated with Voriconazole

Marjolaine Morgand; Blandine Rammaert; S. Poirée; Marie-Elisabeth Bougnoux; Hugo Tran; Romain Kania; Fabrice Chrétien; Grégory Jouvion; Olivier Lortholary

ABSTRACT Invasive aspergillosis (IA) is a severe disseminated fungal disease that occurs mostly in immunocompromised patients. However, central nervous system IA, combining meningitis and skull base involvement, does not occur only in groups with classic risk factors for IA; patients with chronic renal failure and diabetes mellitus are also at risk for more chronic forms. In both of our proven IA cases, voriconazole monotherapy was effective without surgery, and cerebrospinal fluid and serum 1,3-β-d-glucan test results were initially positive, in contrast to galactomannan antigen results.


American Journal of Pathology | 2015

Absence of Fungal Spore Internalization by Bronchial Epithelium in Mouse Models Evidenced by a New Bioimaging Approach and Transmission Electronic Microscopy

Blandine Rammaert; Grégory Jouvion; Fabrice de Chaumont; Dea Garcia-Hermoso; Claire Szczepaniak; Charlotte Renaudat; Jean-Christophe Olivo-Marin; Fabrice Chrétien; Françoise Dromer; Stéphane Bretagne

Clinical data and experimental studies suggest that bronchial epithelium could serve as a portal of entry for invasive fungal infections. We therefore analyzed the interactions between molds and the bronchial/bronchiolar epithelium at the early steps after inhalation. We developed invasive aspergillosis (Aspergillus fumigatus) and mucormycosis (Lichtheimia corymbifera) murine models that mimic the main clinical risk factors for these infections. Histopathology studies were completed with a specific computer-assisted morphometric method to quantify bronchial and alveolar spores and with transmission electron microscopy. Morphometric analysis revealed a higher number of bronchial/bronchiolar spores for A. fumigatus than L. corymbifera. The bronchial/bronchiolar spores decreased between 1 and 18 hours after inoculation for both fungi, except in corticosteroid-treated mice infected with A. fumigatus, suggesting an effect of cortisone on bronchial spore clearance. No increase in the number of spores of any species was observed over time at the basal pole of the epithelium, suggesting the lack of transepithelial crossing. Transmission electron microscopy did not show spore internalization by bronchial epithelial cells. Instead, spores were phagocytized by mononuclear cells on the apical pole of epithelial cells. Early epithelial internalization of fungal spores in vivo cannot explain the bronchial/bronchiolar epithelium invasion observed in some invasive mold infections. The bioimaging approach provides a useful means to accurately enumerate and localize the fungal spores in the pulmonary tissues.


Transplant Infectious Disease | 2017

Thalidomide for steroid‐dependent chronic disseminated candidiasis after stem cell transplantation: A case report

Blandine Rammaert; Sophie Candon; Christophe Maunoury; Marie-Elisabeth Bougnoux; Grégory Jouvion; Thorsten Braun; Jean-Michel Correas; Olivier Lortholary

Chronic disseminated candidiasis (CDC) is a rare and difficult‐to‐treat invasive fungal disease occurring mainly after prolonged and profound neutropenia. We describe the case of a 59‐year‐old man successfully treated with thalidomide for CDC recurrences after an autologous transplantation. We add evidence of the effectiveness of immunomodulatory drugs to manage inflammatory reconstitution immune syndrome‐related refractory CDC.

Collaboration


Dive into the Blandine Rammaert's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Marie-Elisabeth Bougnoux

Necker-Enfants Malades Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Fanny Lanternier

Necker-Enfants Malades Hospital

View shared research outputs
Top Co-Authors

Avatar

O. Lortholary

Necker-Enfants Malades Hospital

View shared research outputs
Top Co-Authors

Avatar

S. Poirée

Necker-Enfants Malades Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge